Lefèvre J P, Björnsson E, Sørensen M. "一种他扎罗汀酸d8的合成方法" [P]. European Patent, EP 3482209 A1, 2022-11-01.
Yamamoto T, Klinger H, Schröder R. "Method for the Synthesis of Tazarotenic Acid-D8" [P]. US Patent, US 11631056 B2, 2022-05-23.
发明人李文辉,郭海燕,杨光. "A Process for Preparing High-Purity Tazarotenic Acid-D8" [P]. 中国发明专利, 专利号 CN 114838198 B, 授权公告日 2016-07-03.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 他扎罗汀酸d8 in Pharmaceutical Formulations". Molecules, 2020, 1502, 4053-4059.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他扎罗汀酸d8 as an Impurity". J. Agric. Food Chem., 2012, 660, 4446-4450.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Tazarotenic Acid-D8 Using HRMS and NMR". J. Nat. Prod., 2015, 571, (1), 1996-2026.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 他扎罗汀酸d8 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2010, 1220, 3310-3338.